LINC01833 (long intergenic non-protein coding RNA 1833) (LINC01833)

ENSG00000274547 corresponds to the LINC01833 gene, which encodes a long intergenic non-protein coding RNA. LINC01833 has been associated in the literature with susceptibility to some cancers, including glioblastoma and lung cancer, but it is not a protein-coding gene and is not considered a canonical therapeutic target such as a receptor, enzyme, transporter, or ion channel[5]. No drugs are known to target this RNA directly, and its detailed mechanisms and clinical relevance remain poorly characterized. This entry is considered incorrect as a therapeutic target, because it is not a protein, enzyme, receptor, or similar molecular entity commonly targeted in drug discovery[1][5].

Other names

LINC01833